Liposomes as nanocarriers for anti-HIV therapy. - Wikidata - wikimedia - TriplyDB

Liposomes as nanocarriers for anti-HIV therapy.

Liposomes as nanocarriers for anti-HIV therapy.

http://www.wikidata.org/entity/Q41195459

about

Regulating the alky chain length of fatty acid-didanosine prodrugs and evaluating its role in albumin binding.

P2860

Q49861125-2CEA57E1-29B4-4730-866D-FF773344AB73

P2860

Liposomes as nanocarriers for anti-HIV therapy.

http://www.wikidata.org/entity/Q41195459

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Liposomes as nanocarriers for anti-HIV therapy.

@en

type

label

Liposomes as nanocarriers for anti-HIV therapy.

@en

prefLabel

Liposomes as nanocarriers for anti-HIV therapy.

@en

P1433

Q41195459-3F09A313-7DD3-440D-B11B-15831E9F9699

P1476

Q41195459-E19BFA33-AB5C-435B-A74E-CBDBE49D11AE

P2093

Q41195459-00190919-0336-4B8C-B87E-602675B0EB6B

Q41195459-521CA212-BE60-4337-9D45-F7FE415BFB1E

Q41195459-ABD57456-AEDC-469A-B039-5FD61695CB5D

P2860

Q41195459-00B69DCD-EE3F-4A8E-BCF4-69691B69D878

Q41195459-013C9BC9-854B-43BE-A887-17BD3F3E0019

Q41195459-084361E5-3E04-4B8D-8290-B466D3A0DDD4

Q41195459-1DAB97E1-AAE4-4F22-9C39-5FBD9E98FFEC

Q41195459-1E410EE6-4448-442B-AB52-7CA6E47BA7DC

Q41195459-34CD168B-9B07-4D55-A8CD-189FD0F21557

Q41195459-39DC68B4-043A-4097-A227-96B51CF9E045

Q41195459-56012205-FC02-418D-9311-76016043A8E0

Q41195459-5DB8CD70-FB10-4EF6-8DCD-915B6E0F9E22

Q41195459-5F35E9F7-2761-4299-9F2A-31D6BED8DB67

P2888

Q41195459-1A5551BA-3C8C-48A5-8FE4-E9DD4F44B0F6

P304

Q41195459-BB730D1B-038D-471D-9A4E-D67AA76E66A7

P31

Q41195459-1B40EA1C-AAAC-44C1-B53E-6478823CA897

P356

Q41195459-5B1499FC-D8D9-4E42-8761-916E1B890DB0

P433

Q41195459-FCA97811-B246-4831-8938-CDBB314BA532

P478

Q41195459-9AD1F4DA-3732-4D9F-9C06-AB0C00B89882

P577

Q41195459-35807D60-766C-41A1-98D5-5BD8F791BDFC

P698

Q41195459-711471CF-DA7D-429C-A9F1-F68B8A5D06B7

P921

Q41195459-D04B3232-7395-4ED2-A675-06B7D7495835

P356

S13346-013-0134-2

P1433

Drug delivery and translational research

P1476

Liposomes as nanocarriers for anti-HIV therapy.

@en

P2093

Guru V Betageri

http://www.w3.org/2001/XMLSchema#string

Natarajan Venkatesan

http://www.w3.org/2001/XMLSchema#string

Shruti Chopra

http://www.w3.org/2001/XMLSchema#string

P2860

The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic

Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes

Recent advances with liposomes as pharmaceutical carriers

Progress in antiretroviral drug delivery using nanotechnology

PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus.

Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells

Gaining a foothold: how HIV avoids innate immune recognition.

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

The critical need for alternative antiretroviral formulations, and obstacles to their development.

Liposomes for HIV prophylaxis.

P2888

s13346-013-0134-2

P304

471-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13346-013-0134-2

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25788354

http://www.w3.org/2001/XMLSchema#string

P921